A unique bleeding-related complication of sorafenib, a tyrosine kinase inhibitor, in advanced hepatocellular carcinoma: a case report

INTRODUCTION: Sorafenib, a multikinase inhibitor as a standard of care for advanced hepatocellular carcinoma, may lead endothelial cells to an unstable state by blocking the signaling pathway of vascular endothelial growth factor receptor, which may result in the disruption of the architecture and i...

Descripción completa

Detalles Bibliográficos
Autores principales: Kang, Ha Yan, Moon, Sung Hoon, Song, Il Han
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3943401/
https://www.ncbi.nlm.nih.gov/pubmed/24571585
http://dx.doi.org/10.1186/1752-1947-8-72

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3943401/
https://www.ncbi.nlm.nih.gov/pubmed/24571585
http://dx.doi.org/10.1186/1752-1947-8-72

Ejemplares similares